New Vaccine Available to Protect Infants From RSV
4 Articles
4 Articles
Since the beginning of October, immunization with long-acting monoclonal antibodies has been available to protect newborns and infants under six months of age from respiratory syncytial virus infection.
With lower temperatures and less sunlight comes the respiratory syncytial virus (RSV) season. Since early October, immunization with long-acting monoclonal antibodies has been available to protect newborns and infants under six months of age against RSV infection.
With lower temperatures and less insolation comes the season of respiratory syncytial virus (RSV) infections. Since early October, immunization with long-acting monoclonal antibodies has been available to protect newborns and infants under six months of age from RSV infection, experts said at an event on protecting infants from RSV. Every year, RSV causes [...]
Maternity hospitals and pediatricians now offer parents of newborns the option of direct protection against respiratory syncytial virus, which can cause extremely serious problems in the youngest. These are long-acting antibodies, while public health also offers the option of indirect protection during pregnancy.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
